Gilead Sciences, Inc. (Nasdaq: GILD) is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need, with primary focus areas including HIV/AIDS, viral hepatitis…
HQ: Foster City, CA, United States of Americawww.gilead.com
USD143.72-0.75%vs prev. close
Market snapshot
Price
USD143.72
Daily move
-0.75%
P/E
—
EPS TTM
-2.64
Dividend yield
2.28%
Beta
0.35
Market cap
178.2B
Price history
GILD price
USD
No price history available
Next earnings
No upcoming earnings report scheduled in the next 6 months.
Peer comparison
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Gilead Sciences
GILD
Drug Manufacturers - General
178.2
—
2.28%
-4.8%
+5.8%
+14.4%
-0.9%
+21.9%
+17.1%
🔒
Subscribe to Equity Analytics to compare GILD with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.